Head and Neck Cancer Trial, Recruiting NCT05988060 Sponsor: Institute Verbeeten Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT05988060
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have head and neck cancer and are scheduled to receive radiation therapy, with or without chemotherapy or targeted therapy
  • People who are 18 years of age or older
  • People who can read and write in Dutch well enough to participate
  • People who have a reasonable level of general health and ability to carry out daily activities, as measured by a standard medical scoring tool (confirm with trial site)
  • People who are able to walk at least 60 metres without using a walking aid or mobility device
  • People who have no medical reasons to avoid physical activity, based on a standard health screening questionnaire

Who may not be able to join:

  • People whose head and neck cancer has come back after previous treatment
  • People who have a second, separate head and neck cancer diagnosis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yvette Kriellaars, Msc., Instituut Verbeeten

Phone: +3188758040

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institute Verbeeten
Registry
ClinicalTrials.gov
Start date
9 November 2022
Est. completion
9 November 2025

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

physical performance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov